AU Stock MarketDetailed Quotes

Neuren Pharmaceuticals Ltd (NEU)

Watchlist
  • 12.470
  • +0.010+0.08%
20min DelayMarket Closed May 1 16:00 AET
1.58BMarket Cap53.52P/E (Static)

Neuren Pharmaceuticals Ltd (NEU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2025
(FY)Dec 30, 2024
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
(FY)Dec 30, 2020
(FY)Dec 30, 2019
(FY)Dec 30, 2018
(FY)Dec 30, 2017
(FY)Dec 30, 2016
Total revenue
-69.69%64.63M
-8.06%213.24M
1,493.66%231.93M
14.55M
13.54M
Operating revenue
-69.69%64.63M
-8.06%213.24M
1,493.66%231.93M
--14.55M
----
----
----
--13.54M
----
----
Cost of revenue
Gross profit
-69.69%64.63M
-8.06%213.24M
1,493.66%231.93M
14.55M
13.54M
Operating expense
13.11%42.63M
15.22%37.69M
102.45%32.71M
41.27%16.16M
20.00%11.44M
-17.65%9.53M
40.25%11.58M
21.69%8.25M
-55.52%6.78M
-12.08%15.25M
Selling and administrative expenses
32.27%6.22M
-20.94%4.7M
73.00%5.95M
79.57%3.44M
8.56%1.91M
2.92%1.76M
-17.41%1.71M
32.27%2.07M
-42.48%1.57M
-12.63%2.73M
-General and administrative expense
32.27%6.22M
-20.94%4.7M
73.00%5.95M
79.57%3.44M
8.56%1.91M
2.92%1.76M
-17.41%1.71M
32.27%2.07M
-42.48%1.57M
-12.63%2.73M
Research and development costs
10.38%36.39M
23.25%32.97M
110.44%26.75M
33.59%12.71M
22.58%9.52M
-21.25%7.76M
61.58%9.86M
18.79%6.1M
-58.72%5.14M
-11.97%12.44M
Depreciation amortization depletion
4.55%23K
29.41%22K
70.00%17K
25.00%10K
33.33%8K
50.00%6K
-94.87%4K
0.00%78K
-2.50%78K
-11.11%80K
-Depreciation and amortization
4.55%23K
29.41%22K
70.00%17K
25.00%10K
33.33%8K
50.00%6K
-94.87%4K
0.00%78K
-2.50%78K
-11.11%80K
Operating profit
-87.47%22M
-11.88%175.55M
12,504.17%199.21M
85.96%-1.61M
-20.00%-11.44M
17.65%-9.53M
-318.77%-11.58M
178.02%5.29M
55.52%-6.78M
12.08%-15.25M
Net non-operating interest income (expenses)
10.40%12.16M
93.67%11.01M
1,354.48%5.69M
853.66%391K
-72.11%41K
-62.21%147K
78.44%389K
363.83%218K
-75.00%47K
-43.88%188K
Non-operating interest income
10.40%12.16M
93.67%11.01M
1,354.48%5.69M
853.66%391K
-72.11%41K
-62.21%147K
78.44%389K
363.83%218K
-75.00%47K
-43.88%188K
Other net income (expenses)
230.17%4.75M
-1,720.44%-3.65M
-83.80%225K
-61.36%1.39M
1,832.80%3.6M
-49.18%186K
114.56%366K
-125.28%-2.51M
787.15%9.95M
-59.55%1.12M
Other non-operating income (expenses)
230.17%4.75M
-1,720.44%-3.65M
-83.80%225K
-61.36%1.39M
1,832.80%3.6M
-49.18%186K
114.56%366K
-125.28%-2.51M
787.15%9.95M
-59.55%1.12M
Income before tax
-78.72%38.93M
-10.82%182.94M
111,389.13%205.14M
102.36%184K
15.22%-7.79M
15.01%-9.19M
-451.97%-10.82M
225.99%3.07M
82.40%-2.44M
2.04%-13.86M
Income tax
-79.23%8.49M
-14.90%40.9M
48.06M
0
0
0
0
0
65.78%-631K
-146.19%-1.84M
Earnings from equity interest net of tax
Net income
-78.57%30.44M
-9.57%142.04M
85,270.11%157.08M
102.36%184K
15.22%-7.79M
15.01%-9.19M
-451.97%-10.82M
269.97%3.07M
84.95%-1.81M
10.32%-12.01M
Net income continuous operations
-78.57%30.44M
-9.57%142.04M
85,270.11%157.08M
102.36%184K
15.22%-7.79M
15.01%-9.19M
-451.97%-10.82M
269.97%3.07M
84.95%-1.81M
10.32%-12.01M
Noncontrolling interests
Net income attributable to the company
-78.57%30.44M
-9.57%142.04M
85,270.11%157.08M
102.36%184K
15.22%-7.79M
15.01%-9.19M
-451.97%-10.82M
269.97%3.07M
84.95%-1.81M
10.32%-12.01M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-78.57%30.44M
-9.57%142.04M
85,270.11%157.08M
102.36%184K
15.22%-7.79M
15.01%-9.19M
-451.97%-10.82M
269.97%3.07M
84.95%-1.81M
10.32%-12.01M
Diluted earnings per share
-78.65%0.2373
-10.06%1.1117
82,300.00%1.236
102.27%0.0015
23.26%-0.066
20.37%-0.086
-448.39%-0.108
263.16%0.031
86.43%-0.019
12.50%-0.14
Basic earnings per share
-78.57%0.2327
-9.57%1.0861
79,966.67%1.201
102.27%0.0015
23.26%-0.066
20.37%-0.086
-448.39%-0.108
263.16%0.031
86.43%-0.019
12.50%-0.14
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2025(FY)Dec 30, 2024(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021(FY)Dec 30, 2020(FY)Dec 30, 2019(FY)Dec 30, 2018(FY)Dec 30, 2017(FY)Dec 30, 2016
Total revenue -69.69%64.63M-8.06%213.24M1,493.66%231.93M14.55M13.54M
Operating revenue -69.69%64.63M-8.06%213.24M1,493.66%231.93M--14.55M--------------13.54M--------
Cost of revenue
Gross profit -69.69%64.63M-8.06%213.24M1,493.66%231.93M14.55M13.54M
Operating expense 13.11%42.63M15.22%37.69M102.45%32.71M41.27%16.16M20.00%11.44M-17.65%9.53M40.25%11.58M21.69%8.25M-55.52%6.78M-12.08%15.25M
Selling and administrative expenses 32.27%6.22M-20.94%4.7M73.00%5.95M79.57%3.44M8.56%1.91M2.92%1.76M-17.41%1.71M32.27%2.07M-42.48%1.57M-12.63%2.73M
-General and administrative expense 32.27%6.22M-20.94%4.7M73.00%5.95M79.57%3.44M8.56%1.91M2.92%1.76M-17.41%1.71M32.27%2.07M-42.48%1.57M-12.63%2.73M
Research and development costs 10.38%36.39M23.25%32.97M110.44%26.75M33.59%12.71M22.58%9.52M-21.25%7.76M61.58%9.86M18.79%6.1M-58.72%5.14M-11.97%12.44M
Depreciation amortization depletion 4.55%23K29.41%22K70.00%17K25.00%10K33.33%8K50.00%6K-94.87%4K0.00%78K-2.50%78K-11.11%80K
-Depreciation and amortization 4.55%23K29.41%22K70.00%17K25.00%10K33.33%8K50.00%6K-94.87%4K0.00%78K-2.50%78K-11.11%80K
Operating profit -87.47%22M-11.88%175.55M12,504.17%199.21M85.96%-1.61M-20.00%-11.44M17.65%-9.53M-318.77%-11.58M178.02%5.29M55.52%-6.78M12.08%-15.25M
Net non-operating interest income (expenses) 10.40%12.16M93.67%11.01M1,354.48%5.69M853.66%391K-72.11%41K-62.21%147K78.44%389K363.83%218K-75.00%47K-43.88%188K
Non-operating interest income 10.40%12.16M93.67%11.01M1,354.48%5.69M853.66%391K-72.11%41K-62.21%147K78.44%389K363.83%218K-75.00%47K-43.88%188K
Other net income (expenses) 230.17%4.75M-1,720.44%-3.65M-83.80%225K-61.36%1.39M1,832.80%3.6M-49.18%186K114.56%366K-125.28%-2.51M787.15%9.95M-59.55%1.12M
Other non-operating income (expenses) 230.17%4.75M-1,720.44%-3.65M-83.80%225K-61.36%1.39M1,832.80%3.6M-49.18%186K114.56%366K-125.28%-2.51M787.15%9.95M-59.55%1.12M
Income before tax -78.72%38.93M-10.82%182.94M111,389.13%205.14M102.36%184K15.22%-7.79M15.01%-9.19M-451.97%-10.82M225.99%3.07M82.40%-2.44M2.04%-13.86M
Income tax -79.23%8.49M-14.90%40.9M48.06M0000065.78%-631K-146.19%-1.84M
Earnings from equity interest net of tax
Net income -78.57%30.44M-9.57%142.04M85,270.11%157.08M102.36%184K15.22%-7.79M15.01%-9.19M-451.97%-10.82M269.97%3.07M84.95%-1.81M10.32%-12.01M
Net income continuous operations -78.57%30.44M-9.57%142.04M85,270.11%157.08M102.36%184K15.22%-7.79M15.01%-9.19M-451.97%-10.82M269.97%3.07M84.95%-1.81M10.32%-12.01M
Noncontrolling interests
Net income attributable to the company -78.57%30.44M-9.57%142.04M85,270.11%157.08M102.36%184K15.22%-7.79M15.01%-9.19M-451.97%-10.82M269.97%3.07M84.95%-1.81M10.32%-12.01M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -78.57%30.44M-9.57%142.04M85,270.11%157.08M102.36%184K15.22%-7.79M15.01%-9.19M-451.97%-10.82M269.97%3.07M84.95%-1.81M10.32%-12.01M
Diluted earnings per share -78.65%0.2373-10.06%1.111782,300.00%1.236102.27%0.001523.26%-0.06620.37%-0.086-448.39%-0.108263.16%0.03186.43%-0.01912.50%-0.14
Basic earnings per share -78.57%0.2327-9.57%1.086179,966.67%1.201102.27%0.001523.26%-0.06620.37%-0.086-448.39%-0.108263.16%0.03186.43%-0.01912.50%-0.14
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More